Despite the loss of PBRM1 protein expression in many cases of cancer-associated PBRM1 mutations (46, 71), this study highlights the clinical relevance of cancer-associated PBRM1-BD4 missense variants with variable stability and histone Kac binding compared to the WT protein. Here, PBRM1 is linked to cancer.